107 related articles for article (PubMed ID: 12846174)
21. PSG consensus statement on management of hepatitis C virus infection--2003.
Hamid S; Umar M; Alam A; Siddiqui A; Qureshi H; Butt J;
J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
[No Abstract] [Full Text] [Related]
22. Pegylated interferon alpha-2b in patients with acute hepatitis C.
Mukhopadhyay A
Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
[No Abstract] [Full Text] [Related]
23. Treatment of acute C hepatitis in intravenous drug users.
Bargiacchi O; Audagnotto S; Garazzino S; De Rosa FG
J Hepatol; 2005 Jul; 43(1):186-7. PubMed ID: 15893846
[No Abstract] [Full Text] [Related]
24. Delaying HCV treatment in HIV-positive patients.
Carter M
IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
[No Abstract] [Full Text] [Related]
25. Quality of life with pegylated interferon therapy for hepatitis C.
Brown RS
Hepatology; 2002 Sep; 36(3):767-8; author reply 768. PubMed ID: 12198677
[No Abstract] [Full Text] [Related]
26. Reply to issues raised in the Jansen/Reesink editorial.
Silva M
J Hepatol; 2007 Feb; 46(2):350-1. PubMed ID: 17161883
[No Abstract] [Full Text] [Related]
27. Second thoughts about secondary analyses.
Ferenci P
Dig Liver Dis; 2005 Oct; 37(10):805-7; author reply 808-9. PubMed ID: 16023903
[No Abstract] [Full Text] [Related]
28. Treatment of acute hepatitis C-how to explain the differences?
Wedemeyer H; Cornberg M; Wiegand J; Jäckel E; Manns MP
Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627
[No Abstract] [Full Text] [Related]
29. Hepatitis C virus infection.
Bacon BR; Di Bisceglie AM
N Engl J Med; 2001 Nov; 345(19):1425-6; author reply 1427-8. PubMed ID: 11794183
[No Abstract] [Full Text] [Related]
30. Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.
Bruchfeld A; Lindahl K; Stahle L; Schvarcz R
J Hepatol; 2006 Feb; 44(2):432-3; author reply 433. PubMed ID: 16338023
[No Abstract] [Full Text] [Related]
31. Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
Riley TR
Hepatology; 2008 Jan; 47(1):356; author reply 356-7. PubMed ID: 18161713
[No Abstract] [Full Text] [Related]
32. [Long-acting interferon: studies on pegylated interferon].
Ma H; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):78-9. PubMed ID: 11856520
[No Abstract] [Full Text] [Related]
33. [Progression of treatment of hepatitis C--peginterferon].
Pawłowska M; Halota W
Przegl Epidemiol; 2001; 55 Suppl 3():169-73. PubMed ID: 11984947
[No Abstract] [Full Text] [Related]
34. [Recent advances in the treatment of the acute hepatitis C].
Palumbo E
Recenti Prog Med; 2007 Apr; 98(4):236-7. PubMed ID: 17547361
[TBL] [Abstract][Full Text] [Related]
35. Successful liver transplantation and treatment of recurrent hepatitis C using pegylated alpha-interferon in a patient with Churg-Strauss disease.
Falkensammer J; Bonatti H; Dickson RC; Norman K; Nguyen J; Hinder R; Aranda-Michel J
Transpl Int; 2007 Feb; 20(2):190-4. PubMed ID: 17239028
[TBL] [Abstract][Full Text] [Related]
36. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
[No Abstract] [Full Text] [Related]
37. Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?
Sierra F
J Hepatol; 2007 Feb; 46(2):349; author reply 349-50. PubMed ID: 17161495
[No Abstract] [Full Text] [Related]
38. Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.
Teta D; Lüscher BL; Gonvers JJ; Francioli P; Phan O; Burnier M
Nephrol Dial Transplant; 2005 May; 20(5):991-3. PubMed ID: 15741205
[No Abstract] [Full Text] [Related]
39. Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.
Wiegand J; Deterding K; Cornberg M; Wedemeyer H
J Antimicrob Chemother; 2008 Nov; 62(5):860-5. PubMed ID: 18776191
[TBL] [Abstract][Full Text] [Related]
40. Acute hepatitis C: dosage and compliance.
De Rosa F; Cariti G; Di Perri G
Hepatology; 2006 Aug; 44(2):511; author reply 511-2. PubMed ID: 16871564
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
